|
New Delhi, Jan 15: Nepal on Friday granted approval for AstraZeneca’s COVISHIELD vaccine against the novel coronavirus in the country.
Representational Image
The decision to grant the approval for the vaccine was taken on Friday, Nepal”s Department of Drug Administration (DDA) said in a statement.
“Conditional permission has been granted for emergency use authorisation of Covishield vaccine against COVID-19 in Nepal,” the statement said.
Drug major AstraZeneca has partnered with the Pune-based Serum Institute of India (SII), the world”s largest vaccine manufacturer, for the supply of the vaccine to the Indian government and also to a large number of low and middle-income countries.
What are the…
